These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 588304
41. Excitatory input from sensory motor cortex to neostriatum and its modification by conditioning stimulation of the substantia nigra. Hirata K, Yim CY, Mogenson GJ. Brain Res; 1984 Oct 29; 321(1):1-8. PubMed ID: 6093925 [Abstract] [Full Text] [Related]
42. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]? Arbuthnott GW, Garcia-Munoz M, Nicolaou NM, Tulloch IF, Wright AK. Br J Pharmacol; 1976 Oct 29; 58(2):272P. PubMed ID: 974393 [No Abstract] [Full Text] [Related]
43. On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain. Waldmeier PC, Feldtrauer JJ. Biochem Pharmacol; 1987 Sep 01; 36(17):2855-61. PubMed ID: 3632711 [Abstract] [Full Text] [Related]
44. Serotonin--dopamine interactions in the nigrostriatal system. Waldmeier PC, Delini-Stula AA. Eur J Pharmacol; 1979 May 15; 55(4):363-73. PubMed ID: 572774 [Abstract] [Full Text] [Related]
45. Reserpine-insensitive dopamine release in the substantia nigra? Elverfors A, Nissbrandt H. Brain Res; 1991 Aug 23; 557(1-2):5-12. PubMed ID: 1720998 [Abstract] [Full Text] [Related]
46. [Stereotyped behavior and the nigro-strio-nigral system]. Arushanian EB. Zh Vyssh Nerv Deiat Im I P Pavlova; 1985 Aug 23; 35(5):819-32. PubMed ID: 2866641 [No Abstract] [Full Text] [Related]
47. Reversal of nigrostriatal-lesion-induced receptor alterations by grafting of fetal mesencephalic dopaminergic neurons. Wamsley JK, Dawson TM, Dawson VL, Hunt MA, Fisher LJ, Gage FH. Adv Exp Med Biol; 1991 Aug 23; 287():221-35. PubMed ID: 1759609 [No Abstract] [Full Text] [Related]
48. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems. Koob GF, Del Fiacco M, Iversen SD. Adv Biochem Psychopharmacol; 1977 Aug 23; 16():589-95. PubMed ID: 560793 [No Abstract] [Full Text] [Related]
49. The role of substance P in the nigrostriatal system. Borison RL, Klawans HL, Diamond BI. Int J Neurol; 1980 Aug 23; 14(2-4):189-94. PubMed ID: 6194132 [No Abstract] [Full Text] [Related]
50. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Robinson TE, Whishaw IQ. Brain Res; 1988 May 31; 450(1-2):209-24. PubMed ID: 3135914 [Abstract] [Full Text] [Related]
51. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain. Westerink BH, Korf J. Eur J Pharmacol; 1976 Jun 31; 37(2):249-55. PubMed ID: 954808 [Abstract] [Full Text] [Related]
52. Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions. Pehek EA, Crock R, Yamamoto BK. Synapse; 1992 Apr 31; 10(4):317-25. PubMed ID: 1374937 [Abstract] [Full Text] [Related]
53. Antibacterial activity of tropolone. Trust TJ. Antimicrob Agents Chemother; 1975 May 31; 7(5):500-6. PubMed ID: 1147585 [Abstract] [Full Text] [Related]
54. Decrease in glucose oxidation in isolated brown fat cells from rats due to tropolone and dimethoxybenzene. Rosenthal JW. Gen Pharmacol; 1981 May 31; 12(1):47-50. PubMed ID: 7250667 [No Abstract] [Full Text] [Related]
57. A comparative study of the properties of the catechol-O-methyltransferase inhibitors, U-0521 and tropolone acetamide, in rat perfused heart. Bryan LJ, Fleig H, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb 31; 322(1):6-19. PubMed ID: 6843690 [No Abstract] [Full Text] [Related]